Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib

Nika Finelt*, Rishi R. Lulla, Hector Melin-Aldana, Jennifer Shuley Ruth, Frank Y. Lin, Jack M. Su, Crystal Y. Pourciau, Raegan D. Hunt, Brandi M. Kenner-Bell

*Corresponding author for this work

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Vemurafenib is increasingly being used to treat nonmelanoma tumors that are positive for the BRAF V600E mutation. We report three children who presented with panniculitis induced by vemurafenib while undergoing treatment for central nervous system tumors and review the literature.

Original languageEnglish (US)
Pages (from-to)337-341
Number of pages5
JournalPediatric dermatology
Volume34
Issue number3
DOIs
StatePublished - May 1 2017

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Dermatology

Fingerprint Dive into the research topics of 'Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib'. Together they form a unique fingerprint.

  • Cite this

    Finelt, N., Lulla, R. R., Melin-Aldana, H., Ruth, J. S., Lin, F. Y., Su, J. M., Pourciau, C. Y., Hunt, R. D., & Kenner-Bell, B. M. (2017). Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib. Pediatric dermatology, 34(3), 337-341. https://doi.org/10.1111/pde.13148